What is the role for molecular agents alone for medically inoperable NSCLC who is not a good candidate for chemoRT?
How would you integrate RT with molecular agents?
Answer from: Radiation Oncologist at Academic Institution
If medically inoperable and deemed not a chemo candidate, my preference would be definitive RT alone using a hypofractionated approach to account for the absence of radiosensitizing chemotherapy even for patients with targetable driver mutations. The best data we currently have would then say to con...